-
ImmunityBio (NASDAQ:IBRX) Receives "Buy" Rating from D. Boral Capital
Source: Buzz FX / 25 Nov 2024 08:46:09 America/New_York
ImmunityBio (NASDAQ:IBRX) Receives "Buy" Rating from D. Boral Capital Written by MarketBeat November 25, 2024 Share Link copied to clipboard. ImmunityBio ( NASDAQ:IBRX - Get Free Report ) 's stock had its "buy" rating reissued by analysts a
Read more...